Article · Journal · 2024

Exploring the potential of 2-arylbenzimidazole scaffolds as novel α-amylase inhibitors: QSAR, molecular docking, simulation and pharmacokinetic studies

Khalifa Sunusi Aminu, Adamu Uzairu, Anshuman Chandra, Nagendra Singh, Stephen E. Abechi, Gideon Adamu Shallangwa and 1 more

In Silico Pharmacology

• Open access · Green
• International · 2 countries

Read it10.1007/s40203-024-00205-4